" class="no-js "lang="en-US"> Hervé Perron - Medtech Alert
Thursday, March 28, 2024
Hervé Perron

Hervé Perron

About Hervé Perron

Hervé has a PhD in Virology and wrote a doctoral dissertation on neuroimmunology. He is the author of over 120 peer-reviewed publications and patents and is a referee for various scientific journals. He was Research Director of R&D within bioMérieux for the development of in vitro diagnostics for neurological diseases. Hervé was Scientific Director of bioMérieux STELHYS, a spin-off dedicated to the evaluation of developments in upstream research projects. Hervé is a co-founder and Chief Scientific Officer of GeNeuro and the general manager of GeNeuro-Innovation.

Related Story

Syndrome Post-COVID: First Results of the Collaboration Between Fondamental & GeNeuro

April 13 2022

GeNeuro (Euronext Paris: CH0308403085 – GNRO), a biopharmaceutical company developing new treatments for neurodegenerative and autoimmune […]